Cronvall operates a B2B e‑commerce marketplace that consolidates over 100 suppliers and 5,000 industrial items into a single digital catalog with real‑time pricing and inventory visibility. The platform automates order confirmation, electronic invoicing with 30‑day payment terms, and shipment tracking, streamlining bulk procurement for construction, manufacturing and facilities‑management teams. Suppliers use a dedicated portal to sync product data, manage stock, and access sales analytics.

This startup develops a parallel computing intellectual property that enhances CPU performance while maintaining full backward compatibility with existing processors and applications. By enabling processor manufacturers to streamline control and common components, the technology addresses inefficiencies in scaling parallelism in personal computing devices and smartphones.

Gesynta Pharma develops pharmaceuticals that inhibit the pro-inflammatory enzyme mPGES-1 to reduce inflammation and pain associated with chronic conditions like endometriosis. Their lead candidate, Vipoglanstat, is currently in phase II clinical trials, demonstrating significant reductions in endometrial lesions and pain-related symptoms.

The startup develops a technology that processes methane into hydrogen and solid carbon without emitting carbon dioxide, utilizing a method that separates methane into its elemental components. This approach enables industries to convert natural gas or biogas into clean hydrogen fuel and high-quality carbon, addressing the need for sustainable energy sources and reducing greenhouse gas emissions.

Hypermine offers a laser-based hyperspectral sensing system that provides real-time mineralogy characterization at the mine site. This technology enables truck load resolution decision-making, improving ore grade control and operational efficiency by up to 100x compared to traditional block models.

NPHarvest utilizes proprietary technology based on hydrophobic membrane stripping and calcium precipitation to recover nitrogen and phosphorus from wastewater streams. This process efficiently captures key nutrients, converting them into high-quality ammonia salt and calcium phosphate suitable for fertilizer production. The result is reduced environmental impact for municipalities and industries while creating valuable resources for agriculture.

Polar Night Energy develops high-temperature thermal energy storage systems, known as Sand Batteries, that utilize sand as a medium to store renewable energy in the form of heat. This technology provides a reliable solution for energy self-sufficiency and grid balancing, enabling the transition from fossil fuels to sustainable energy sources.

Sooma Medical provides the EU MDR‑approved Sooma tDCS™ system, a portable transcranial direct current stimulation device that delivers non‑invasive, drug‑free brain‑stimulation therapy for major depressive disorder and chronic pain. The solution combines a certified hardware headset with a cloud‑based platform for remote protocol management, real‑time session monitoring, and data‑driven clinical adjustments, enabling clinics and hospitals to scale treatment and reduce patient wait times.

StemSight develops off-the-shelf cell therapies using induced pluripotent stem (iPS) cells combined with functional biomaterials to regenerate retinal cells. The company targets corneal blindness caused by degenerative eye diseases, aiming to restore vision through effective cellular interventions.